Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 01, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Stellar Biotechnologies Appoints Two Members to SAB
Saturday, June 07, 2014
Appointment of Gregory T. Baxter and Charles V. Olson to the Company's Scientific Advisory Board.

Humanity's Overall Environmental Footprint is Not Sustainable
Friday, June 06, 2014
Substantial, fundamental changes in the world economy are required to reduce humanity's overall environmental footprint to a sustainable level.

Ventana, MedImmune to Develop a custom Assay Immunotherapy for Clinical Trials
Thursday, June 05, 2014
Companies are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma.

Separation of mAbs Molecular Variants by Analytical HIC-HPLC
Thursday, June 05, 2014
HIC-HPLC is a less widely used analytical technique compared with standard methods for separating variants based on size, charge or electrophoretic mobility.

Arena Initiates Phase 1b Trial for Autoimmune Disease Drug
Wednesday, June 04, 2014
Trial will evaluate safety, tolerability and pharmacokinetics of APD334 for treatment of a number of autoimmune diseases.

Merck’s Melanoma Drug Shows Overall Survival Rate of 69%
Wednesday, June 04, 2014
Pembrolizumab as monotherapy shows estimated overall survival rate at one year across 411 advanced melanoma patients with varying stages of disease and prior therapy.

Agalimmune Receives £1.2 million ($2 million) Milestone Payment
Wednesday, June 04, 2014
Agalimmune’s Alphaject technology, an injectable oncology therapy has completed a Phase I trial in melanoma. Data presented at AACR and ASCO.

SCT Changes its Name to Trillium Therapeutics Inc.
Tuesday, June 03, 2014
Company has filed articles of amalgamation to merge with Trillium Therapeutics.

Adaptimmune, GSK to Develop and Commercialise Novel Cell-Based Therapies
Monday, June 02, 2014
Adaptimmune enters a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialisation of its lead clinical cancer programme.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1137
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv